Biotron initiates Phase IIa clinical trial in HCV patients
Biotron claims that BIT225 is a new drug with the potential to improve treatment options for HCV patients. The Phase IIa clinical trial is a combination study of
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
Wellbutrin XL (bupropion hydrochloride) is an antidepressant of the aminoketone class and is chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor, or other known antidepressant agents. Wellbutrin